FDA
approval
· 2025-08-01
FDA Approved: LIOMNY — Supplemental Application (SIGMAPHARM LABORATORIES, LLC)
Summary
FDA approved a supplemental application for LIOMNY (liothyronine sodium) from SigmaPharm Laboratories LLC.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for LIOMNY (LIOTHYRONINE SODIUM)